Alison J Ford

Author PubWeight™ 5.24^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.	J Med Chem	2010	1.06
2	In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.	J Pharmacol Exp Ther	2012	1.03
3	Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.	J Med Chem	2013	0.82
4	Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.	Bioorg Med Chem Lett	2012	0.82
5	Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.	J Med Chem	2009	0.77
6	Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.	J Med Chem	2013	0.77
7	The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.	Bioorg Med Chem	2011	0.75
8	Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo.	Eur J Pharmacol	2005	0.75
9	The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.	Bioorg Med Chem	2011	0.75